Cytotoxic activity was evaluated against the MCF-7 breast cancer cell line using the MTT assay, whereas the in silico study was evaluated using molecular docking and molecular dynamics against the epidermal growth factor receptor (EGFR). This evidence concerns the gene EGFR and breast carcinoma.